CD177 and autoimmune disease: Dysregulation of CD177+ neutrophils, resulting in immune overactivation, is a key mechanism in autoimmune diseases, and the mean fluorescence intensity (MFI) of CD177+ neutrophils may serve as a novel biomarker for assessing disease activity in SLE.